Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphoma
Crossref DOI link: https://doi.org/10.1038/s41571-019-0255-8
Published Online: 2019-07-15
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alencar, Alvaro J.
Moskowitz, Craig H.
Text and Data Mining valid from 2019-07-15
Version of Record valid from 2019-07-15
Article History
First Online: 15 July 2019
Competing interests
: The authors declare no competing interests.